Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study

Abstract

BackgroundCardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites.Methodology/Principal FindingsParticipants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis.Conclusions/SignificancePlasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.

Increased Levels of Both Th1 and Th2 Cytokines in Subjects with Metabolic Syndrome (CURES-103)

“…Furthermore, population-specific (ethnic) differences in systemic cytokine profiles are well documented. 34 The role played by inflammation in MS is complex and multifaceted. 25 Both systemic and organ-specific inflammation is involved in the disease process.…”

Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis

“…Women have higher levels of factor VIII, von Willebrand factor and fibrinogen than men but there is no evidence of a difference in the amount of fibrinolytic activity. [13][14][15] Of interest, gender differences have been described in other clinical settings. 16 The severity of thrombocytopenia was identified as a risk factor for bleeding.…”

Enabling Computational Proteomics by Public and Local Data Management Systems

“…Finally, the latter illustrates another asset of targeted proteomics: its capability to monitor multiple proteins in a single experiment, thereby becoming a good fit for the emerging multimodal nature of human diseases. 3 …”

“…The oldest gel-based method is 2D gelelectrophoresis (2DGE), and it remains highly used because of the ability to visualize modified proteins and protein isoforms efficiently. 2,3 Two commonly applied chromatography-based methods, MUDPIT (multidimensional protein identification technology) 4 and GeLC-MS/MS (in-gel tryptic digestion followed by liquid chromatography-MS/MS), 5 illustrate the capability of proteomics to create comprehensive proteome maps, rivaling even the sensitivity of tandem affinity purification and green fluorescent protein-tagged benchmark proteomes. 6 The main strength of shotgun proteomics techniques is that they yield a large sampling scope of the proteome composition.…”